Cytokinetics Inc annual free cash flow for fiscal TTM was -$580 million, a decrease of 8.4% from -$535 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($580M) | ($535M) | ($400M) | ($416M) | ($311M) | ($191M) | ($2M) | ($94M) | ($102M) | ($105M) | $35M | $4M | ($46M) | ($8M) | ($34M) | ($46M) | ($45M) | $8M | ($62M) | ($6M) | ($53M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($164M) | ($151M) | ($148M) | ($117M) | ($132M) | ($137M) | ($67M) | ($104M) | ($101M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CYTK metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All CYTK financial statements → Interactive CYTK charts →
About TickerBase · Data methodology & sources · Privacy · Terms